DCM
ASMB icon

DAFNA Capital Management’s Assembly Biosciences ASMB Stock Holding History

DAFNA Capital Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,964
Closed -$585K – 78
2020
Q3 		$585K Hold
2,964
– – 0.19% 71
2020
Q2 		$830K Hold
2,964
– – 0.24% 61
2020
Q1 		$528K Hold
2,964
– – 0.22% 65
2019
Q4 		$728K Sell
2,964
-1,250
-30% -$230K 0.25% 63
2019
Q3 		$497K Hold
4,214
– – 0.19% 71
2019
Q2 		$682K Hold
4,214
– – 0.26% 65
2019
Q1 		$996K Hold
4,214
– – 0.43% 49
2018
Q4 		$1.14M Buy
4,214
+3,325
+374% +$962K 0.57% 47
2018
Q3 		$396K Buy
+889
New +$416K 0.16% 63

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

DAFNA Capital Management's ASMB Position: Q4 2020 in Review

DAFNA Capital Management sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 2,964 shares — an estimated $585K sold.

DAFNA Capital Management first reported a position in ASMB in Q3 2018 and held it in 9 quarters. The position peaked at $1.14M in Q4 2018. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • DAFNA Capital Management reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
  • DAFNA Capital Management sold 2,964 Assembly Biosciences shares in Q4 2020, an estimated $585K.
  • DAFNA Capital Management first reported a position in Assembly Biosciences in Q3 2018 and held it in 9 quarters.
  • DAFNA Capital Management's Assembly Biosciences position peaked at $1.14M in Q4 2018.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on DAFNA Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.